Table 2 Clinical characteristics of children with idiopathic nephrotic syndrome (INS) (n = 181)
Characteristic | Valuesa |
|---|---|
Age of onset of INS (year) | 3.7 [2.3, 8.0] |
Age of diagnosis of INS (year) | 3.7 [2.3,7.7] |
First-time visit of the hospital, yes | 54 (29.8) |
Number of visiting tertiary hospitals in the last 6Â months | 2 (1, 3) |
Presence of hematuria, yes | 9 (5.0) |
Renal insufficiency, yes | 18 (9.9) |
Presence of hypertension, yes | 11 (6.1) |
Only using the steroid, yes | 50 (27.6) |
Medications used for treatment except for steroid | |
 Oral immunosuppressive drug | 88 (48.6) |
 Rituximab | 51 (28.2) |
 Other medications | 51 (28.2) |
Immunosuppressive medications used for treatment | |
 Levamisole | 1 (0.6) |
 Mycophenolate mofetil | 41 (22.7) |
 Cyclophosphamide | 5 (2.8) |
 Tacrolimus | 58 (32.0) |
 Cyclosporine A | 7 (3.9) |
 Other | 5 (2.8) |
Primary concern regarding illness perceived by parents | |
 Nephrotic syndrome cannot be cured | 129 (71.3) |
 The physical discomforts caused by INS | 11 (6.1) |
 Psychological problems caused by INS | 8 (4.4) |
 Concerns about adverse effects of medications | 12 (6.6) |
 Concerns about sequelae | 9 (5.0) |
 The negative impact of illness on children's education | 3 (1.7) |
 Psychological problems of caregivers | 1 (0.6) |
 The financial burden due to the disease | 7 (3.9) |
 Other concerns | 1 (0.6) |